181 related articles for article (PubMed ID: 34272152)
21. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
Ihnen M; Köhler N; Kersten JF; Milde-Langosch K; Beck K; Höller S; Müller V; Witzel I; Jänicke F; Kilic E
Dis Markers; 2010; 28(2):71-8. PubMed ID: 20364042
[TBL] [Abstract][Full Text] [Related]
22. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Ihnen M; Müller V; Wirtz RM; Schröder C; Krenkel S; Witzel I; Lisboa BW; Jänicke F; Milde-Langosch K
Breast Cancer Res Treat; 2008 Dec; 112(3):419-27. PubMed ID: 18172759
[TBL] [Abstract][Full Text] [Related]
23. ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient's Response to Chemotherapies.
Yang YM; Ruge F; Ji KE; Jia S; Jia Y; Sanders AJ; Ji J; Jiang WG
Anticancer Res; 2023 Apr; 43(4):1463-1475. PubMed ID: 36974802
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract.
Levin TG; Powell AE; Davies PS; Silk AD; Dismuke AD; Anderson EC; Swain JR; Wong MH
Gastroenterology; 2010 Dec; 139(6):2072-2082.e5. PubMed ID: 20826154
[TBL] [Abstract][Full Text] [Related]
25. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
26. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
27. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
28. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
[TBL] [Abstract][Full Text] [Related]
29. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
Liang S; Huang C; Jia S; Wang B
Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
[TBL] [Abstract][Full Text] [Related]
30. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
Swart GW
Eur J Cell Biol; 2002 Jun; 81(6):313-21. PubMed ID: 12113472
[TBL] [Abstract][Full Text] [Related]
31. Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.
Curis C; Percher F; Jeannin P; Montange T; Chevalier SA; Seilhean D; Cartier L; Couraud PO; Gout O; Gessain A; Ceccaldi PE; Afonso PV
J Virol; 2016 Aug; 90(16):7303-7312. PubMed ID: 27252538
[TBL] [Abstract][Full Text] [Related]
32. Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.
Hansen AG; Freeman TJ; Arnold SA; Starchenko A; Jones-Paris CR; Gilger MA; Washington MK; Fan KH; Shyr Y; Beauchamp RD; Zijlstra A
Cancer Res; 2013 May; 73(10):2955-64. PubMed ID: 23539446
[TBL] [Abstract][Full Text] [Related]
33. Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.
Hebron KE; Li EY; Arnold Egloff SA; von Lersner AK; Taylor C; Houkes J; Flaherty DK; Eskaros A; Stricker TP; Zijlstra A
Sci Rep; 2018 Feb; 8(1):3208. PubMed ID: 29453336
[TBL] [Abstract][Full Text] [Related]
34. Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population.
Zhou P; Du LF; Lv GQ; Yu XM; Gu YL; Li JP; Zhang C
Breast Cancer Res Treat; 2011 Jul; 128(2):527-34. PubMed ID: 21293922
[TBL] [Abstract][Full Text] [Related]
35. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M
Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448
[TBL] [Abstract][Full Text] [Related]
36. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
37. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
Ihnen M; Kress K; Kersten JF; Kilic E; Choschzick M; Zander H; Müller V; Mahner S; Jänicke F; Woelber L; Milde-Langosch K
BMC Cancer; 2012 Apr; 12():140. PubMed ID: 22475274
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients.
Sawhney M; Matta A; Macha MA; Kaur J; DattaGupta S; Shukla NK; Ralhan R
Int J Cancer; 2009 May; 124(9):2098-105. PubMed ID: 19142865
[TBL] [Abstract][Full Text] [Related]
39. ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors.
Morosi LG; Piperno GM; López L; Amadio R; Joshi S; Rustighi A; Del Sal G; Benvenuti F
Oncoimmunology; 2024; 13(1):2367843. PubMed ID: 38887373
[TBL] [Abstract][Full Text] [Related]
40. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers.
Yang YM; Ye L; Ruge F; Fang Z; Ji K; Sanders AJ; Jia S; Hao C; Dou QP; Ji J; Jiang WG
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]